SIN - Italian Society of Nephrology's Avatar

SIN - Italian Society of Nephrology

@sinnefro.bsky.social

Official account of Italian Society of Nephrology - Account ufficiale della Società Italiana di Nefrologia (SIN)

430 Followers  |  653 Following  |  4 Posts  |  Joined: 28.11.2024  |  1.7975

Latest posts by sinnefro.bsky.social on Bluesky

Preview
Kidney Commute NKF Mega Menu

Dialysis is a miracle—but have we begun to take it for granted?

This episode challenges us to rethink how dialysis has shaped nephrology’s priorities, innovation, and identity.

🎧 bit.ly/3DamjQ9

#KidneyCommute #Dialysis #Medical #Nephrology

12.02.2026 01:00 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image

Simultaneous initiation of finerenone and empagliflozin was effective and well tolerated among CONFIDENCE study participants from Asia, consistent with the overall population ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/40965042/

11.02.2026 13:25 — 👍 2    🔁 1    💬 0    📌 0
Post image

Classic Fred Luft #Nephrology 101 editorial on a study testing the effect of potassium supplement on natriuresis: Eliminating sodium with potassium 🔗 academic.oup.com/ndt/article/... #NephSky #MedSky 🧪

03.02.2026 20:25 — 👍 7    🔁 6    💬 1    📌 0
Preview
Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon ABSTRACT. Immunoglobulin A nephropathy (IgAN) remains the most common primary glomerulonephritis globally. Advances in mucosal immunology have illuminated

Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon

doi.org/10.1093/ckj/...

27.01.2026 12:21 — 👍 1    🔁 1    💬 0    📌 0
Post image

Risk-based referral model to nephrologist specialist care in Stockholm

doi.org/10.1093/ndt/...

27.01.2026 12:22 — 👍 1    🔁 2    💬 0    📌 0
scott brimble

scott brimble

#NephGR tomorrow!

@sbrimble.bsky.social on TMA in cancer and the St Joe’s Hamilton onconephrology program

#NephSky

22.01.2026 02:23 — 👍 6    🔁 4    💬 0    📌 1
Post image

In a #ASNCJASN Kidney Cross-Talk, authors explore recent evidence on Lipoprotein(a) and chronic kidney disease (CKD). Read more: kidney.pub/CJASN0968 Bob Roshanravan

19.01.2026 19:00 — 👍 2    🔁 2    💬 0    📌 0
Post image

CKD for the Primary Care Provider ca. 2026
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41152063/

19.01.2026 23:18 — 👍 3    🔁 2    💬 0    📌 0
Post image

🔬 New Data Deserves a Platform! The Late-Breaking Abstract Call for SCM26 is open.

📌 Must include results from major clinical trials or epidemiological studies to be considered for review.

Learn More: bit.ly/47TaBq4

#Nephrology #MedEd #NKFClinicals #NephSky

17.01.2026 21:01 — 👍 0    🔁 1    💬 0    📌 0
Post image

Environmental Impacts of Kidney Replacement Therapies: A Comparative Lifecycle Assessment

bit.ly/3KNKibh #OpenAccess

17.01.2026 23:00 — 👍 0    🔁 1    💬 0    📌 0
Post image

The January issue of Kidney News is now online! Topics this month include:

⦁ A special section on Kidney Watch 2026, top areas to watch this year in nephrology
⦁ The ASN President's Update and new strategic plan

Explore the issue: kidney.pub/KN1801-01 #ASNKidneyNews Kenar Jhaveri, MD

08.01.2026 21:00 — 👍 3    🔁 2    💬 0    📌 0

The Italian Society of Nephrology expresses its deep sorrow for the passing of Prof. Claudio Ponticelli, a pioneer in nephrology and an outstanding scientist and mentor. Our heartfelt condolences to his family and colleagues. #RIP #Nephrology

02.01.2026 12:11 — 👍 4    🔁 2    💬 0    📌 0
Post image

Erectile dysfunction is prevalent among patients with CKD. Read about the mechanisms and treatments at this intersection in #ASNKidneyNews kidney.pub/KN1712-14

25.12.2025 18:00 — 👍 1    🔁 1    💬 0    📌 0
Breakdown of solved cases by gene category. Breakdown of the solved uKF cases by gene and phenotypic category. All percentages represent a proportion of the total solved cases (n=38). ADTKD, autosomal dominant tubulointerstitial kidney disease; CAKUT, congenital anomalies of the kidneys and urinary tract.

Breakdown of solved cases by gene category. Breakdown of the solved uKF cases by gene and phenotypic category. All percentages represent a proportion of the total solved cases (n=38). ADTKD, autosomal dominant tubulointerstitial kidney disease; CAKUT, congenital anomalies of the kidneys and urinary tract.

Quantifying APOL1, Human Leukocyte Antigen, and Other Genetic Contributions to Unexplained Kidney Failure #OpenAccess

bit.ly/4nfGoXe

20.12.2025 23:00 — 👍 2    🔁 2    💬 0    📌 0
Post image

#CKDs at the Crossroads: From Failures to #Future #Therapies

https://doi.org/10.1016/j.ekir.2025.09.050

#KIRReview

19.12.2025 18:00 — 👍 3    🔁 1    💬 0    📌 1
Post image

📣Calling all #ResidentDoctors & #MedicalStudents! Thinking about a career in #Nephrology? join our taster event!

Hear from renal registrars & consultants, learn about key conditions, explore career pathways & get tips for CVs & interviews.

👉https://ow.ly/YXRr50XyH0y

#RenalMedicine #KidneyCare

02.12.2025 07:00 — 👍 0    🔁 2    💬 0    📌 0
Preview
Bioengineering and nephrology converge to drive kidney-targeted therapies Nature Reviews Nephrology, Published online: 26 November 2025; doi:10.1038/s41581-025-01037-xEffective kidney-targeted therapeutics require careful consideration of both the cargo and carrier. In the past year, considerable progress has been made in the development of viral and non-viral delivery vehicles, by leveraging endogenous biological mechanisms, screening across multiple species and administration routes, and artificial intelligence to drive kidney selectivity.
02.12.2025 12:11 — 👍 0    🔁 1    💬 0    📌 0
Post image

NEW on #AJKDBlog:

AJKDBlog’s Interviews Editor, Timothy Yau chatted with Kristen L. Nowak and Michel Chonchol about the complicated interplay between CKD and systemic inflammation, and new targets/pathways that could improve kidney and cardiovascular outcomes.

bit.ly/4o63tv6 (FREE)

24.11.2025 23:00 — 👍 1    🔁 1    💬 0    📌 0
Post image

𝗜𝗡𝗦𝗜𝗚𝗛𝗧 is out! 🌍
✨WCN’26 joint sessions
✨ New onconephrology case
✨ ISN Journal summaries on APOL1 kidney disease and expanding peritoneal dialysis in India
✨ New language of Kidney Health Quiz (Swahili) and ISN SGLT2i Toolkit (German and Spanish)
and more! ➡️http://lite.spr.ly/6...

25.11.2025 09:37 — 👍 0    🔁 1    💬 0    📌 0
Post image Post image Post image Post image

#UrinarySediment from a pt with #AKI #RPGN due to suspected MPO-AAV-GN inspected with Sternheimer stain: WBC cast (bright field), broad RBC cast (bright), waxy cast (bright), and granular cast w/Ca Oxalate monohydrate crystals (oblique). #OchsnerNephrology #UrineMicroscopy

22.11.2025 21:31 — 👍 7    🔁 4    💬 0    📌 0
Preview
CaseHippo One platform for interactive learning, engagement and collaborative knowledge

Explores practical strategies for nutrition care in older adults with CKD. Learn how to integrate medical nutrition therapy with geriatric care using the 5 M’s framework and support individualized approaches for complex patients.

📚

22.11.2025 22:00 — 👍 1    🔁 1    💬 0    📌 1
Preview
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction Sodium/glucose co-transporter 2 inhibitors (SGLT2i) slow the progression of chronic kidney disease (CKD) and heart failure without the risk of concomitant

Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction

doi.org/10.1093/ndt/...

20.11.2025 10:00 — 👍 2    🔁 2    💬 0    📌 0
Preview
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution Nature Reviews Nephrology, Published online: 31 October 2025; doi:10.1038/s41581-025-01017-1Implementation of the recently adopted World Health Organization resolution on kidney health will require not only additional funding, but also strategic investment. Embedding kidney health interventions into primary care and community-based non-communicable disease prevention and treatment platforms can rebalance resource allocation across the care continuum, improving both sustainability and fairness.
06.11.2025 02:09 — 👍 1    🔁 1    💬 0    📌 0
Post image

⚠ @kireports.bsky.social November issue is out!

Read the latest news in research, highlights from current literature, comprehensive reviews, and in-depth case studies.

www.kireports.org/cu...

#ThisIsISN #Nephrology #Journal #Research #KidneyCommunity #Kidney #OpenAccess

06.11.2025 06:00 — 👍 2    🔁 2    💬 1    📌 0
Post image

The November 2025 issue is available now! Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:

bit.ly/3X1XpZj

30.10.2025 10:00 — 👍 2    🔁 2    💬 0    📌 0
What's New in PD Patient Training? - recorded webinar
What's New in PD Patient Training? - recorded webinar

The recording of our joint webinar with @theisn.org: "What's New in Patient Training", focused on the recently published Position Paper on Teaching #PeritonealDialysis to Patients and Caregivers, is already available on our Youtube channel:
buff.ly/P2N0NGV

24.10.2025 06:45 — 👍 2    🔁 2    💬 1    📌 0
program for thursday at kidney wk

including 2 LBCTs and Vlado P talking on RCTs and curing kidney disease

program for thursday at kidney wk including 2 LBCTs and Vlado P talking on RCTs and curing kidney disease

The opening plenary at #KidneyWk looks phenomenal

Renal RCT Renaissance is upon us

(LBCT list drops tomorrow)

www.asn-online.org/education/ki...

16.10.2025 13:10 — 👍 20    🔁 12    💬 2    📌 1
 The Mayo Imaging Classification of ADPKD description (left panel) and imaging examples (right panel) with examples (right panel) of (a, b) subclass 1A and 1E, (c-f) subclass 2A, and (g, h) subclass 2B. Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; TKV, total kidney volume. Reproduced with permission of the copyright holder (Kidney Disease: Improving Global Outcomes) from Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int. 2025;107(suppl 2S):S1-S239. doi:10.1016/j.kint.2024.07.009

The Mayo Imaging Classification of ADPKD description (left panel) and imaging examples (right panel) with examples (right panel) of (a, b) subclass 1A and 1E, (c-f) subclass 2A, and (g, h) subclass 2B. Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; TKV, total kidney volume. Reproduced with permission of the copyright holder (Kidney Disease: Improving Global Outcomes) from Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int. 2025;107(suppl 2S):S1-S239. doi:10.1016/j.kint.2024.07.009

Core Curriculum by Craig E. Gordon et al:

Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025
bit.ly/465twwK (FREE)

03.10.2025 22:00 — 👍 6    🔁 1    💬 0    📌 0

Excellent thread below

I will also plug this talk by Paola Romagnani on podocytopathies

youtu.be/bRMeqaGgA9I?...

#GlomCon #NephGR

24.09.2025 00:00 — 👍 11    🔁 5    💬 0    📌 0
Green nephrology: from evidence to action Nature Reviews Nephrology, Published online: 11 September 2025; doi:10.1038/s41581-025-01005-5In the past 20 years, awareness of the huge environmental impact of kidney care has increased considerably. Although opportunities to reduce this impact have been identified and innovative approaches developed, implementation of these strategies remains slow. System-wide action is urgently required to improve the sustainability of kidney care.
17.09.2025 04:33 — 👍 2    🔁 3    💬 0    📌 0

@sinnefro is following 18 prominent accounts